Skip to main content
Eupraxia Pharmaceuticals Inc. (EPRX)
NASDAQ: EPRX · Real-Time Price · USD
8.06
+0.43 (5.64%)
Nov 11, 2026, 4:00 PM EST - Market closed

Eupraxia Pharmaceuticals Ratios and Metrics

Millions USD. Fiscal year is Jan - Dec.

Total Valuation

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Market Capitalization
5303811121115828
Market Cap Growth
91.67%241.41%0.65%90.50%111.19%-
Enterprise Value
43732210296438
Last Close Price
8.067.553.174.162.692.30

Price Ratios

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
PB Ratio
4.384.743.51124.328.081.83
P/TBV Ratio
5.797.2965.7050.067.481.75

Financial Efficiency

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Debt / Equity Ratio
0.030.000.0011.711.250.52
Net Debt / Equity Ratio
-1.02-1.00-1.04-9.96-1.29-1.04
Net Debt / EBITDA Ratio
1.862.101.230.320.531.12
Net Debt / FCF Ratio
2.732.761.100.430.631.31
Quick Ratio
11.9414.4410.741.016.0013.38
Current Ratio
12.2515.1211.101.026.0813.49
Return on Equity (ROE)
-56.44%-68.76%-157.31%-715.19%-178.04%-
Return on Assets (ROA)
-36.57%-39.67%-61.14%-88.37%-52.20%-68.51%
Return on Capital Employed (ROCE)
-53.60%-47.70%-84.80%-3120.70%-109.70%-61.90%

Yields

Fiscal Year
CurrentFY 2025FY 2024FY 2023FY 2022FY 2021
Period Ending
Nov '26 Dec '25 Dec '24 Dec '23 Dec '22 Dec '21
Earnings Yield
-12.60%-10.12%-22.84%-25.44%-31.75%-68.66%
FCF Yield
-8.52%-7.64%-26.96%-18.77%-25.12%-43.73%
Buyback Yield / Dilution
-67.80%-17.76%-40.52%-25.21%-55.45%-102.75%
SEC Filings: 10-K · 10-Q